Relationship between programmed death-ligand 1 and clinicopathological characteristics in non-small cell lung cancer patients

Chinese Medical Sciences Journal

Volumn 28, Issue 3, 2013, Pages 147-151

  Chen, Yan Yan ^a   Wang, Liu Bo ^a   Zhu, Hui Li ^a   Li, Xiang Yang ^a   Zhu, Yan Ping ^a   Yin, Yu Lei ^a   Lü, Fan Zhen ^a   Wang, Zi Li ^a   Qu, Jie Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

non small cell lung cancer; programmed death ligand 1; tumor associated macrophage

Indexed keywords

CD68 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CELL DIFFERENTIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PROTEIN EXPRESSION; SMOKING; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD274; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MACROPHAGES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84885633682     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(13)60040-1     Document Type: Article

References (14)

1. H Dong, G Zhu, K Tamada et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Nat Med 5 1999 1365 1369
2. M Sznol, L Chen Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer Clin Cancer Res 19 2013 1021 1034
3. Q Gao, XY Wang, SJ Qiu et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma Clin Cancer Res 15 2009 971 979
4. Q Gao, SJ Qiu, J Fan et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol 25 2007 2586 2593
5. E Bigelow, KM Bever, H Xu et al. Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue J Vis Exp 3 2013 4059
6. YB Chen, CY Mu, JA Huang et al. Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: A 5-year-follow-up study Tumori 98 2012 751 755
7. J Zhang, KW Shen, G Liu et al. Antigen profiles of disseminated tumor cells and microenviromental characteristics in bone marrow of breast cancer Eur J Surg Oncol 29 2003 121 126
8. XL Fu, XZ Zhu, DR Shi et al. Study of prognostic predictors for non-small cell lung cancer Lung Cancer 23 1999 143 152
9. Y Zhang, S Huang, D Gong et al. Programmed death-1 up regulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer Cell Mol Immunol 7 2010 389 395
10. DY Lin, Y Tanaka, M Iwasaki et al. The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors Proc Natl Acad Sci USA 105 2008 3011 3016
11. T Yamazaki, H Akiba, H Iwai et al. Expression of programmed death 1 ligands by murine T cells and APC J Immunol 169 2002 5538 5545
12. CY Mu, JA Huang, Y Chen et al. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation Med Oncol 28 2011 682 688
13. J Konishi, K Yamazaki, M Azuma et al. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression Clin Cancer Res 10 2004 5094 5100
14. I Wistuba Molecular changes in invasion, tumor progression and metastasis: M15-03 J Thorac Oncol 2 2007 S192